Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer

AIM: We previously developed two antibodies that bind to a cell surface protein, perlecan, overexpressed in triple-negative breast cancer (TNBC). The goal of this study was to investigate these antibodies as targeting ligands for nanoparticle-mediated drug delivery. METHODS: Paclitaxel-loaded poly(D...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Future Drug Discov
Главные авторы: Khanna, Vidhi, Kalscheuer, Stephen, Kirtane, Ameya, Zhang, Wenqiu, Panyam, Jayanth
Формат: Artigo
Язык:Inglês
Опубликовано: Newlands Press Ltd 2019
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6700713/
https://ncbi.nlm.nih.gov/pubmed/31448368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fdd-2019-0005
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы